Production lines for GSK

  • Client

    GlaxoSmithKline France

GlaxoSmithKline launched a competition for design engineering and NOX Group came out on top.

The competition was based on creating an autonomous production unit for a new dispensing system for strong inhalers, “the Discus”, for people suffering from asthma.

The preliminary study was based on functional design for a building that had to be adapted to DIsKUS products and its specifications, whilst also remaining sufficiently flexible to be able to cope with any probable future changes. NOX Group then worked on the preliminary drafts to specify the steps taken in the preliminary studies. The detailed studies meant that construction was quick to start.

The patterns for increasing the DISKUS project meant that GSK continued to work with NOX Group on phases 2 and 3, spread out from June 2000 to June 2005.

The entire project was thus carried out in 3 phases and spread over 6 years:

  • Constructing a unit with a surface area of 6,500 m2 including a building for automatic storage for the different material (raw material, material being used and the finished products), an adjacent building with supporting functions, a building for secondary manufacturing and packaging, laboratories for quality control and an area for administration and social needs. 2 production lines were installed as of June 2000 and a third was created between 2001 and 2002;
  • Demolishing 3 buildings and constructing a unit with a surface area of 7,500m2, made up of 3 buildings (storage, reception and manufacturing) done consecutively to those in the first phase;
  • Installing a high-speed production line.